REVISED CO-MARKETING AGREEMENTCo-Marketing Agreement • March 22nd, 2013 • Rosetta Genomics Ltd. • Pharmaceutical preparations
This Revised Co-Marketing Agreement (the “Agreement”) dated October 11, 2012, and which has come into effect on 1 September, 2012 (the “Effective Date”) is by and between Rosetta Genomics Ltd., and its subsidiary, Rosetta Genomics Inc., a Delaware corporation, with offices at 3711 Market St., Suite 740, Philadelphia, PA 19104, USA (collectively, the “Company”) and Precision Therapeutics, Inc., a Delaware corporation with offices at 2516 Jane Street, Pittsburgh, PA 15203, USA (“Precision”).
